Tove F. Tvedskov
Herlev, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Patient-reported pain after targeted axillary dissection for breast cancer.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: June 24, 2026
Axillary Recurrence and Survival After Omission of Axillary Lymph Node Dissection in Patients with Breast Cancer and Micrometastases or Isolated Tumor Cells in the Sentinel Node: A Danish National Register Study.
Journal: Annals of surgical oncology
Published: April 28, 2026
The impact of drains on postoperative seroma and infection after mastectomy: A retrospective study in Danish women with breast cancer.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: February 23, 2026
Perioperative hypersensitivity reactions to Patent Blue V in sentinel lymph node biopsy for breast cancer and melanoma.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: December 02, 2025
Micrometastatic axillary disease after neoadjuvant treatment.
Journal: The Lancet. Oncology
Published: October 10, 2025
Surgical treatment of breast fibroadenomas.
Journal: Danish medical journal
Published: October 10, 2025
Reply to "Comment on TAD Outcomes from the Danish Breast Cancer Group Database".
Journal: Annals of surgical oncology
Published: September 09, 2025
ASO Author Reflections: Is Axillary Lymph Node Dissection Always Justified for Residual Axillary Disease in Breast Cancer After Neoadjuvant Chemotherapy?
Journal: Annals of surgical oncology
Published: August 21, 2025
Oncologic First Events in Breast Cancer Patients After Targeted Axillary Dissection.
Journal: Annals of surgical oncology
Published: June 11, 2025
Additional Axillary Disease After Neoadjuvant Chemotherapy for Patients with Clinically Node-Negative but Sentinel Node-Positive Disease.
Journal: Annals of surgical oncology
Published: May 13, 2025
Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years.
Journal: Breast (Edinburgh, Scotland)
Published: September 27, 2024
Axillary clearance and chemotherapy rates in ER+HER2- breast cancer: secondary analysis of the SENOMAC trial.
Journal: The Lancet regional health. Europe
Published: June 30, 2024
Last Updated: 09/26/2026